Navidea Biopharmaceuticals Inc (OTCPK:NAVB)
$ 0.025 -0.005 (-16.67%) Market Cap: 2.50 Mil Enterprise Value: 397,000.00 PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Navidea Biopharmaceuticals Inc To Discuss Company Strategy and Clinical Update Call Transcript

Apr 20, 2022 / 09:00PM GMT
Release Date Price: $1.09 (+10.10%)
Operator

Greetings. Welcome to the Navidea business update, company strategy and clinical update. (Operator Instructions) Please note this conference is being recorded. I will now turn the conference over to your host, Dr. Michael Rosol. You may begin.

Michael Stanley Rosol
Navidea Biopharmaceuticals, Inc. - Senior VP & Chief Medical Officer

Thank you, and thank you all for joining us today for this update and Q&A session. This call is being webcast live on our website, ir.navidea.com, and a replay will be made available. Following prepared remarks, we will be conducting an open question-and-answer segment focused on our strategy and clinical updates that will be moderated by me, Mike Rosol; and include the Chair of our Board of Directors, Alex Cappello, joined by our Vice Chair of the Board, Kim Scott, who's here with me in Dublin, Ohio; and Erika Eves, our VP of Finance and Administration, who's also here with me in Dublin, Ohio.

During the course of this conference call, we will be making forward-looking statements regarding future events and the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot